EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA Pol II inhibition activates cell death independently from the loss of transcription

Nicholas W Harper, Gavin A Birdsall, Megan E Honeywell, Kelly M Ward, Athma A Pai, Michael J Lee

Cell · 2025-10 · 188 (22) · 6301-6316.e29

DOI: 10.1016/j.cell.2025.07.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-10. Verfasst von Nicholas W Harper und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, UMass Chan Medical School, Worcester, MA 01605, USA. Hauptthemen laut MEDLINE: RNA Polymerase II, Apoptosis, Transcription, Genetic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA Pol II-mediated transcription is essential for eukaryotic life. Although loss of transcription is thought to be universally lethal, the associated mechanisms promoting cell death are not yet known. Here, we show that death following the loss of RNA Pol II activity does not result from dysregulated gene expression. Instead, it occurs in response to loss of the hypophosphorylated form of Rbp1 (also called RNA Pol IIA). Loss of RNA Pol IIA exclusively activates apoptosis, and expression of a transcriptionally inactive version of Rpb1 rescues cell viability. Using functional genomics, we identify the mechanisms driving lethality following the loss of RNA Pol IIA, which we call the Pol II degradation-dependent apoptotic response (PDAR). Using the genetic dependencies of PDAR, we identify clinically used drugs that owe their lethality to a PDAR-dependent mechanism. Our findings unveil an apoptotic signaling response that contributes to the efficacy of a wide array of anti-cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Polymerase IIApoptosisTranscription, GeneticHumans

Stichwörter der Autor:innen

BCL2L12DNA damagePTBP1RNA polymerase IIapoptosiscancer therapycell deathchemotherapycisplatintranscription

Substanzen

RNA Polymerase II

Autor:innen und Institutionen

  • Department of Systems Biology, UMass Chan Medical School, Worcester, MA 01605, USA.
  • RNA Therapeutics Institute, UMass Chan Medical School, Worcester, MA 01605, USA.
  • Department of Systems Biology, UMass Chan Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine and Department of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA 01605, USA…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Harper, N. W., Birdsall, G. A., Honeywell, M. E., Ward, K. M., Pai, A. A., & Lee, M. J. (2025). RNA Pol II inhibition activates cell death independently from the loss of transcription. Cell, 188(22), 6301-6316.e29. https://doi.org/10.1016/j.cell.2025.07.034

Vancouver

Harper NW, Birdsall GA, Honeywell ME, Ward KM, Pai AA, Lee MJ. RNA Pol II inhibition activates cell death independently from the loss of transcription. Cell. 2025;188(22):6301-6316.e29. doi:10.1016/j.cell.2025.07.034

BibTeX
@article{Harper2025,
  author = {Harper, Nicholas W and Birdsall, Gavin A and Honeywell, Megan E and Ward, Kelly M and Pai, Athma A and Lee, Michael J},
  title = {RNA Pol II inhibition activates cell death independently from the loss of transcription},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {22},
  pages = {6301--6316.e29},
  doi = {10.1016/j.cell.2025.07.034}
}
Kostenlos starten →